Quantitative Spatial Profiling of Immune Populations in Pancreatic Ductal Adenocarcinoma Reveals Tumor Microenvironment Heterogeneity and Prognostic Biomarkers

Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive disease with poor 5-year survival rates, necessitating identification of novel therapeutic targets. Elucidating the biology of the tumor immune microenvironment (TiME) can provide vital insights into mechanisms of tumor progression. In t...

Descripción completa

Detalles Bibliográficos
Autores principales: Mi, Haoyang, Sivagnanam, Shamilene, Betts, Courtney B., Liudahl, Shannon M., Jaffee, Elizabeth M., Coussens, Lisa M., Popel, Aleksander S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2022
Materias:
Tumor Biology and Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716253/
https://www.ncbi.nlm.nih.gov/pubmed/36112643
http://dx.doi.org/10.1158/0008-5472.CAN-22-1190

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716253/
https://www.ncbi.nlm.nih.gov/pubmed/36112643
http://dx.doi.org/10.1158/0008-5472.CAN-22-1190

Ejemplares similares